Pediatric Pulmonology · 2018 · 19 citations · 17 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsStatistical GeneticsCystic FibrosisFibrosisGenetic DisordersGenetic SusceptibilityMutation AnalysisCftr Gene MutationsCftr Protein FunctionClinical Phenotype PredictionCystic Fibrosis GeneticsDisease-associated Channel Mutations
BACKGROUND: Cystic fibrosis (CF) is due to dysfunction of the CFTR channel and function of this channel is, in turn, affected by modifier genes that can impact the clinical phenotype. In this context, we analyzed the interaction among rs3788766*SLC6A14, rs7512462*SLC26A9, rs17235416*SLC11A1, and rs17563161*SLC9A3 variants, CFTR mutations and 40 CF severity markers by the Multifactor Dimensionality Reduction (MDR) model. METHODS: A total of 164 patients with CF were included in the study. The variants in the modifier genes were identified by real-time PCR and the genotype of the CFTR gene in the diagnostic routine. Analysis of interaction between variants, CFTR mutations groupings and demographic, clinical and laboratory data were performed by the MDR. RESULTS: There were interaction between the rs3788766, rs7512462, rs17235416, and rs17563161 variants, and CFTR mutations with pancreatic insufficiency (PI), onset of digestive symptoms, and presence of mucoid Pseudomonas aeruginosa. Regarding PI, the interaction was observed for CFTR*rs17563161 (P-value = 0.015). Also, for onset of digestive symptoms the interaction was observed for CFTR*rs3788766*rs7512462*rs17235416*rs17563161 (P-value = 0.036). Considering the presence of mucoid P. aeruginosa, the interaction occurred for CFTR*rs3788766*rs7512462*rs17563161 (P-value = 0.035). CONCLUSION: Interaction between variants in the SLC family genes and the grouping for CFTR mutations were associated with PI, onset of digestive symptoms and mucoid P. aeruginosa, being important to determine one of the factors that may cause the diversity among the patients with CF.
17
How does multiple testing correction work?
William Stafford Noble · Nature Biotechnology · 2009 · 784 citations · Full text
Genetic Modifiers of Lung Disease in Cystic Fibrosis
Mitchell L. Drumm, Michael W. Konstan, Mark Schluchter et al. · New England Journal of Medicine · 2005 · 495 citations · Full text